National burden of pediatric hospitalizations for inflammatory bowel disease: Results from the 2006 kids' inpatient database

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 4, 2012, Pages 477-485

  Heaton, Pamela C ^a   Tundia, Namita L ^a   Schmidt, Nicole ^b   Wigle, Patricia R ^a   Kelton, Christina M L ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Crohn disease; inflammatory bowel disease; Kids' Inpatient Database; national burden of illness; ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; FEMALE; HEALTH CARE COST; HOSPITAL; HOSPITAL COST; HOSPITAL PATIENT; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SELECTION; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH CARE COSTS; HOSPITAL CHARGES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFANT; INPATIENTS; LENGTH OF STAY; MALE; PEDIATRICS; YOUNG ADULT;

EID: 84859103656     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318239bc79     Document Type: Article

References (32)

1. Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:62-8.
2. Gibson TB, Eliza N, Ozminkowski RJ, et al. The direct and the indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med 2008;50:1261-72.
3. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309-17.
4. Bickston SJ, Waters HC, Dabbous O, et al. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm 2008;14:352-62. (Pubitemid 351890850)
5. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in United States children and adults. Gastroenterology 2008;135:1907-13.
6. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-9. (Pubitemid 350181588)
7. Mendeloff AI, Calkins BM. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease: From Bench to Bedside. Philadelphia: Lea & Febiger; 1988: 3-34.
8. Calkins BM, Lilienfield AM, Garland CG, et al. Trends inincidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29:913-20. (Pubitemid 14021795)
9. De Boer M, Grootenhuis M, Derkx B, et al. Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2005;11:400-6. (Pubitemid 40542274)
10. Healthcare Cost and Utilization Project. Introduction to the HCUP KIDS' Inpatient Database (KID), 2006. http://www.hcup-us.ahrq.gov/db/nation/kid/kid- 2006-introduction.jspon. Accessed September 21, 2009.
11. Tundia NL, Heaton PC, Kelton CML. The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database. Pharmacoepidemiol Drug Saf 2011;20:666-78.
12. Healthcare Cost and Utilization Project. All Patient Refined Diagnosis Related Groups (APR DRGs) Version 25.0. http://www.hcup-us.ahrq.gov/db/nation/ nis/v25-aprdrg-meth-ovrview.pdf. Accessed September 21, 2009.
13. Wynn B, Beckett M, Hilborne L, et al. Evaluation of severity adjusted DRG system. RAND Health. https://www.cms.gov/reports/downloads/Wynn0307.pdf. Accessed October 21, 2008.
14. Healthcare Cost and Utilization Project. Comorbidity Software Version 3.5. http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed September 21, 2009.
15. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27. (Pubitemid 128456396)
16. Bureau of Labor and Statistics. Consumer Price Index-all urban consumers. CPI for hospital inpatient services. http://www.bls.gov. Accessed June 6, 2010.
17. Nguyen GC, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis 2007;13:1529-35.
18. Nguyen GC, Steinhart AH. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis 2008;14:1688-94.
19. Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7. (Pubitemid 39345874)
20. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-35. (Pubitemid 32756629)
21. Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
22. Cosgrove RF, Al-Atia RF, Jenkins HR. The epidemiology of pediatric inflammatory bowel disease. Arch Dis Child 1996;74:460-1. (Pubitemid 26170048)
23. Sclar DA, Robison LM, Gavrun C, et al. Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor? Gen Hosp Psychiatry 2008;30:73-6. (Pubitemid 350299497)
24. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:862-9. (Pubitemid 40523539)
25. Rubenstein JH, Cong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol 2002;35:151-6. (Pubitemid 34815854)
26. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010;59:1200-6.
27. Saro C, Coba C, Casado MA, et al. Resource use inpatients with Crohn's disease treated with infliximab. Aliment Pharmacol Ther 2007;26:1313-23. (Pubitemid 350064013)
28. Hyams J, Crandall W, Kugathasan S, et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007;132:863-73. (Pubitemid 46454266)
29. Swanson GR, Sedghi S, Farhadi A, et al. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol 2010;44:223-8.
30. Nakamura Y, Labarthe DR. A case-control study of ulcerative colitis with relation to smoking habits and alcohol consumption in Japan. Am J Epidemiol 1994;140:902-11. (Pubitemid 24355553)
31. Boyko EJ, Perera DR, Koepsell TD, et al. Coffee and alcohol use and the risk of ulcerative colitis. Am J Gastroenterol 1989;84:530-4. (Pubitemid 19143075)
32. Healthcare Cost and Utilization Project. KID Description of Data Elements. http://www.hcup-us.ahrq.gov/db/vars/dxn/kidnote.jsp. Accessed June 6, 2011.